Roles of circRNAs in the tumour microenvironment
Q Zhang, W Wang, Q Zhou, C Chen, W Yuan, J Liu… - Molecular cancer, 2020 - Springer
The tumour microenvironment (TME) constitutes the area surrounding the tumour during its
development and has been demonstrated to play roles in cancer-related diseases through …
development and has been demonstrated to play roles in cancer-related diseases through …
The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
DW McMillin, JM Negri, CS Mitsiades - Nature reviews Drug discovery, 2013 - nature.com
The role of stromal cells and the tumour microenvironment in general in modulating tumour
sensitivity is increasingly becoming a key consideration for the development of active …
sensitivity is increasingly becoming a key consideration for the development of active …
Stem cell paracrine actions and tissue regeneration
PR Baraniak, TC McDevitt - Regenerative medicine, 2010 - Taylor & Francis
Stem cells have emerged as a key element of regenerative medicine therapies due to their
inherent ability to differentiate into a variety of cell phenotypes, thereby providing numerous …
inherent ability to differentiate into a variety of cell phenotypes, thereby providing numerous …
Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1α in hepatocellular carcinoma
L Zhang, G Huang, X Li, Y Zhang, Y Jiang, J Shen… - BMC cancer, 2013 - Springer
Background High invasion and metastasis are the primary factors causing poor prognosis of
patients with hepatocellular carcinoma (HCC). However, the molecular mechanisms …
patients with hepatocellular carcinoma (HCC). However, the molecular mechanisms …
Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer
Triple negative breast cancer (TNBC) is a heterogeneous disease at the molecular,
pathologic and clinical levels. To stratify TNBCs, we determined microRNA (miRNA) …
pathologic and clinical levels. To stratify TNBCs, we determined microRNA (miRNA) …
Osteosarcoma
R Gorlick, C Khanna - Journal of bone and mineral research, 2010 - academic.oup.com
It has been difficult to identify the molecular features central to the pathogenesis of
osteosarcoma owing to a lack of understanding of the cell or origin, the absence of …
osteosarcoma owing to a lack of understanding of the cell or origin, the absence of …
Toward a drug development path that targets metastatic progression in osteosarcoma
C Khanna, TM Fan, R Gorlick, LJ Helman… - Clinical Cancer …, 2014 - AACR
Despite successful primary tumor treatment, the development of pulmonary metastasis
continues to be the most common cause of mortality in patients with osteosarcoma. A …
continues to be the most common cause of mortality in patients with osteosarcoma. A …
The tumor microenvironment: the making of a paradigm
IP Witz - Cancer Microenvironment, 2009 - Springer
What has been will be again, what has been done will be done again; there is nothing new
under the sun (Ecclesiastes 1: 9) Stephen Paget was the conceptual father of the role played …
under the sun (Ecclesiastes 1: 9) Stephen Paget was the conceptual father of the role played …
Cancer‐associated fibroblasts and epithelial‐mesenchymal transition in metastatic oral tongue squamous cell carcinoma
M Vered, D Dayan, R Yahalom… - … journal of cancer, 2010 - Wiley Online Library
We examined cancer‐associated fibroblasts (CAFs) and a panel of immunohistochemical
markers of epithelial‐mesenchymal transition (EMT) in 19 pair‐matched oral tongue …
markers of epithelial‐mesenchymal transition (EMT) in 19 pair‐matched oral tongue …
[HTML][HTML] Reverse phase protein microarrays advance to use in clinical trials
Individualizing cancer therapy for molecular targeted inhibitors requires a new class of
molecular profiling technology that can map the functional state of the cancer cell signal …
molecular profiling technology that can map the functional state of the cancer cell signal …